گزارش یک مورد Percutaneous Transluminal Septal Myocardial Ablation در کاردیومیوپاتی هیپرتروفیک
Authors
Abstract:
A number of patients with severe obstruction due to hypertrophic cardiomyopathy have derived benefit at least over the short-term from inventional infarction of a portion of the interventricular septum by the infusion of alcohol into a selectively catheterized septal artery , with reduction of the outflow gradient and improvement in symptoms . This paper contains successful TASH on a symptomatic patient with high LVOT gradient and methods and complications.
similar resources
گزارش یک مورد percutaneous transluminal septal myocardial ablation در کاردیومیوپاتی هیپرتروفیک
تعدادی از بیماران کاردیومیوپاتی هیپرتروفیک که انسداد شدید در مسیر خروجی بطن چپ دارند ، حداقل در کوتاه مدت از ایجاد انفارکت با تزریق انتخابی الکل در شریان سپتال سود می برند که با کاهش گرادیان خروجی بطن و علائم بیمار مشخص می شود . این مطالعه به معرفی انجام موفقیت آمیز سپتال ابلیشن در یک بیمار علامت دار که گرادیان بالای خروجی بطن چپ داشت و متدها و عوارض این روش می پردازد
full textPercutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
BACKGROUND Percutaneous transluminal septal myocardial ablation (PTSMA) has been introduced as an alternative procedure for reducing the left ventricular outflow tract gradient (LVOTG) in hypertrophic obstructive cardiomyopathy. We report on the acute and mid-term results in 91 symptomatic patients with respect to intraprocedural myocardial contrast echocardiography (MCE). METHODS AND RESULTS...
full textFive years of percutaneous transluminal septal myocardial ablation.
In June 1994, Ulrich Sigwart injected a small quantity of absolute alcohol into the first septal artery of a 67 year old woman with hypertrophic obstructive cardiomyopathy. The objective of this somewhat alarming manoeuvre was to produce an area of localised myocardial infarction in the left ventricular outflow tract—in eVect producing a chemical myotomy–myectomy, without recourse to open heart...
full textEditorial Five years of percutaneous transluminal septal myocardial ablation
In June 1994, Ulrich Sigwart injected a small quantity of absolute alcohol into the first septal artery of a 67 year old woman with hypertrophic obstructive cardiomyopathy. The objective of this somewhat alarming manoeuvre was to produce an area of localised myocardial infarction in the left ventricular outflow tract—in eVect producing a chemical myotomy–myectomy, without recourse to open heart...
full textPercutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
BACKGROUND Percutaneous transluminal septal myocardial ablation (PTSMA) by alcohol-induced occlusion of septal branches with resulting reduction of LV outflow-tract gradient (LVOTG) is a new treatment option in symptomatic patients with hypertrophic obstructive cardiomyopathy (HOCM). METHODS In 1996 and 1997 we treated 114 symptomatic patients (56 female; age 53.3 +/- 15.6 years; 5 patients w...
full textTransluminal percutaneous septal myocardial ablation in a patient with hypertrophic obstructive cardiomyopathy.
Reduction of septal mass by inducing septal infarction using catheter techniques is a new therapy for hypertrophic obstructive cardiomyopathy (HOCM). We report a case of severe HOCM that was dramatically improved by this non-surgical treatment. A 60-year-old woman with HOCM had suffered dyspnea (NYHA class III) with syncopal attack despite medical treatment. Left heart catheterization showed a ...
full textMy Resources
Journal title
volume 11 issue 3
pages 62- 64
publication date 2004-12
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023